vadimezan has been researched along with e 7010 in 2 studies
| Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (e 7010) | Trials (e 7010) | Recent Studies (post-2010) (e 7010) |
|---|---|---|---|---|---|
| 272 | 16 | 101 | 81 | 15 | 41 |
| Protein | Taxonomy | vadimezan (IC50) | e 7010 (IC50) |
|---|---|---|---|
| Tubulin alpha-1A chain | Sus scrofa (pig) | 2.945 | |
| Tubulin beta chain | Sus scrofa (pig) | 2.79 | |
| Tubulin beta-4A chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta chain | Homo sapiens (human) | 2.64 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 2.64 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 2.64 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 2.7 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 2.64 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 2.64 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.7 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.7 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 2.64 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 2.64 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Döme, B; Magyar, M | 1 |
| Castaldo, V; Colantuoni, G; Gridelli, C; Maione, P; Rossi, A; Rossi, E; Sacco, PC | 1 |
2 review(s) available for vadimezan and e 7010
| Article | Year |
|---|---|
[Tumor vasculature as a therapeutic target in non-small cell lung cancer].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Axitinib; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Humans; Imidazoles; Indazoles; Indoles; Lung Neoplasms; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperidines; Pyridines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Sorafenib; Sulfonamides; Xanthones | 2008 |
Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Diketopiperazines; Endothelial Cells; Humans; Imidazoles; Lung Neoplasms; Pericytes; Piperazines; Stilbenes; Sulfonamides; Xanthones | 2009 |